Bansisons Tea Industries Renamed Novyra Pharmachem to Reflect Pharma Focus
Bansisons Tea Industries Ltd 路 Others (Uncategorized) 路 22 Aug 2026, 7:33 pm
Bansisons Tea Industries Renamed Novyra Pharmachem to Reflect Pharma Focus Bansisons Tea Industries Limited (BSE: 519353) has been renamed Novyra Pharmachem Limited, effective from 19th Jan'26. This change reflects its strategic expansion into the pharmaceutical and life sciences sectors. The company will now focus on manufacturing and trading APIs, bulk drugs, and specialty chemicals, alongside offering contract research (CRO) and development manufacturing (CDMO) services. This move signals a significant pivot from its previous business into higher-growth pharma-related activities. The company will update its name with exchanges and depositories.
Original exchange filing (PDF)
More announcements from Bansisons Tea Industries Ltd
- Unaudited Financial Results for the quarter ended September 30, 2026 路 02 Nov 2026
- Unaudited financial results for the quarter ended September 30, 2026 路 02 Nov 2026
- Novyra Pharmachem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/11/2026 ,inter alia, to consider and approve Un-Audited Financial Results .... 路 02 Nov 2026
- Intimation under Reg 30 路 24 Sept 2026
- Quarterly Results June 30, 2026 路 14 Aug 2026
- Quarterly Results June 30, 2026 路 14 Aug 2026
- Bansisons Tea Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 ,inter alia, to consider and approve Quarterly Results June 30, 2026 路 14 Aug 2026
- Change of Website 路 04 Aug 2026
